For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

A virus that infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy, say researchers at ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...